Report Detail

Request for Sample of this report

Other Covid-19 Impact on Global Diabetes Devices and Drugs Market Size, Status and Forecast 2020-2026

  • RnM3988671
    • |
  • 05 June, 2020
    • |
  • Global
    • |
  • 125 Pages
    • |
  • QYResearch
    • |
  • Other

Diabetes Devices and Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Devices and Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Diabetes Devices and Drugs market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Diabetes Devices and Drugs industry.

The key players covered in this study
Medtronic
BD
Johnson & Johnson
Abbott Laboratories
Novo Nordisk
Bristol-Myers Squibb
DexCom
Companion Medical
GlaxoSmithKline
Glenmark Pharmaceuticals
Novartis
Roche
Sanofi
MSD
Astrazeneca
Takeda
North China Pharmaceutical Group Corporation
Huadong Medicine
Dongbao Pharmaceutical
Hisun Pharmacy
KELUN
Ginwa
Tianan Pharmaceutical

Market segment by Type, the product can be split into
Diabetes Devices
Diabetes Drugs
Market segment by Application, split into
Diagnostic/Clinics
ICUs
Home Healthcare

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Diabetes Devices and Drugs status, future forecast, growth opportunity, key market and key players.
To present the Diabetes Devices and Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Diabetes Devices and Drugs are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Diabetes Devices and Drugs Revenue
  • 1.4 Covid-19 Implications on Market by Type
    • 1.4.1 Global Diabetes Devices and Drugs Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Diabetes Devices
    • 1.4.3 Diabetes Drugs
  • 1.5 Market by Application
    • 1.5.1 Global Diabetes Devices and Drugs Market Share by Application: 2020 VS 2026
    • 1.5.2 Diagnostic/Clinics
    • 1.5.3 ICUs
    • 1.5.4 Home Healthcare
  • 1.6 Coronavirus Disease 2019 (Covid-19): Diabetes Devices and Drugs Industry Impact
    • 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.6.2 Covid-19 Impact: Commodity Prices Indices
    • 1.6.3 Covid-19 Impact: Global Major Government Policy
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends

  • 2.1 Covid-19 Implications on Global Diabetes Devices and Drugs Market Perspective (2015-2026)
  • 2.2 Covid-19 Implications on Global Diabetes Devices and Drugs Growth Trends by Regions
    • 2.2.1 Diabetes Devices and Drugs Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Diabetes Devices and Drugs Historic Market Share by Regions (2015-2020)
    • 2.2.3 Diabetes Devices and Drugs Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Diabetes Devices and Drugs Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Diabetes Devices and Drugs Players (Opinion Leaders)

3 Covid-19 Implications on Competition Landscape by Key Players

  • 3.1 Global Top Diabetes Devices and Drugs Players by Market Size
    • 3.1.1 Global Top Diabetes Devices and Drugs Players by Revenue (2015-2020)
    • 3.1.2 Global Diabetes Devices and Drugs Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Diabetes Devices and Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Diabetes Devices and Drugs Market Concentration Ratio
    • 3.2.1 Global Diabetes Devices and Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Diabetes Devices and Drugs Revenue in 2019
  • 3.3 Diabetes Devices and Drugs Key Players Head office and Area Served
  • 3.4 Key Players Diabetes Devices and Drugs Product Solution and Service
  • 3.5 Date of Enter into Diabetes Devices and Drugs Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Implications on Market Size by Type (2015-2026)

  • 4.1 Global Diabetes Devices and Drugs Historic Market Size by Type (2015-2020)
  • 4.2 Global Diabetes Devices and Drugs Forecasted Market Size by Type (2021-2026)

5 Covid-19 Implications on Market Size by Application (2015-2026)

  • 5.1 Global Diabetes Devices and Drugs Market Size by Application (2015-2020)
  • 5.2 Global Diabetes Devices and Drugs Forecasted Market Size by Application (2021-2026)

6 North America Impact of COVID-19

  • 6.1 North America Diabetes Devices and Drugs Market Size (2015-2020)
  • 6.2 Diabetes Devices and Drugs Key Players in North America (2019-2020)
  • 6.3 North America Diabetes Devices and Drugs Market Size by Type (2015-2020)
  • 6.4 North America Diabetes Devices and Drugs Market Size by Application (2015-2020)

7 Europe Impact of COVID-19

  • 7.1 Europe Diabetes Devices and Drugs Market Size (2015-2020)
  • 7.2 Diabetes Devices and Drugs Key Players in Europe (2019-2020)
  • 7.3 Europe Diabetes Devices and Drugs Market Size by Type (2015-2020)
  • 7.4 Europe Diabetes Devices and Drugs Market Size by Application (2015-2020)

8 China Impact of COVID-19

  • 8.1 China Diabetes Devices and Drugs Market Size (2015-2020)
  • 8.2 Diabetes Devices and Drugs Key Players in China (2019-2020)
  • 8.3 China Diabetes Devices and Drugs Market Size by Type (2015-2020)
  • 8.4 China Diabetes Devices and Drugs Market Size by Application (2015-2020)

9 Japan Impact of COVID-19

  • 9.1 Japan Diabetes Devices and Drugs Market Size (2015-2020)
  • 9.2 Diabetes Devices and Drugs Key Players in Japan (2019-2020)
  • 9.3 Japan Diabetes Devices and Drugs Market Size by Type (2015-2020)
  • 9.4 Japan Diabetes Devices and Drugs Market Size by Application (2015-2020)

10 Southeast Asia Impact of COVID-19

  • 10.1 Southeast Asia Diabetes Devices and Drugs Market Size (2015-2020)
  • 10.2 Diabetes Devices and Drugs Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Diabetes Devices and Drugs Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Diabetes Devices and Drugs Market Size by Application (2015-2020)

11 India Impact of COVID-19

  • 11.1 India Diabetes Devices and Drugs Market Size (2015-2020)
  • 11.2 Diabetes Devices and Drugs Key Players in India (2019-2020)
  • 11.3 India Diabetes Devices and Drugs Market Size by Type (2015-2020)
  • 11.4 India Diabetes Devices and Drugs Market Size by Application (2015-2020)

12 Central & South America Impact of COVID-19

  • 12.1 Central & South America Diabetes Devices and Drugs Market Size (2015-2020)
  • 12.2 Diabetes Devices and Drugs Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Diabetes Devices and Drugs Market Size by Type (2015-2020)
  • 12.4 Central & South America Diabetes Devices and Drugs Market Size by Application (2015-2020)

13Key Players Profiles

  • 13.1 Medtronic
    • 13.1.1 Medtronic Company Details
    • 13.1.2 Medtronic Business Overview and Its Total Revenue
    • 13.1.3 Medtronic Diabetes Devices and Drugs Introduction
    • 13.1.4 Medtronic Revenue in Diabetes Devices and Drugs Business (2015-2020))
    • 13.1.5 Medtronic Recent Development and Reaction to COVID-19
  • 13.2 BD
    • 13.2.1 BD Company Details
    • 13.2.2 BD Business Overview and Its Total Revenue
    • 13.2.3 BD Diabetes Devices and Drugs Introduction
    • 13.2.4 BD Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 13.2.5 BD Recent Development and Reaction to COVID-19
  • 13.3 Johnson & Johnson
    • 13.3.1 Johnson & Johnson Company Details
    • 13.3.2 Johnson & Johnson Business Overview and Its Total Revenue
    • 13.3.3 Johnson & Johnson Diabetes Devices and Drugs Introduction
    • 13.3.4 Johnson & Johnson Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 13.3.5 Johnson & Johnson Recent Development and Reaction to COVID-19
  • 13.4 Abbott Laboratories
    • 13.4.1 Abbott Laboratories Company Details
    • 13.4.2 Abbott Laboratories Business Overview and Its Total Revenue
    • 13.4.3 Abbott Laboratories Diabetes Devices and Drugs Introduction
    • 13.4.4 Abbott Laboratories Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 13.4.5 Abbott Laboratories Recent Development and Reaction to COVID-19
  • 13.5 Novo Nordisk
    • 13.5.1 Novo Nordisk Company Details
    • 13.5.2 Novo Nordisk Business Overview and Its Total Revenue
    • 13.5.3 Novo Nordisk Diabetes Devices and Drugs Introduction
    • 13.5.4 Novo Nordisk Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 13.5.5 Novo Nordisk Recent Development and Reaction to COVID-19
  • 13.6 Bristol-Myers Squibb
    • 13.6.1 Bristol-Myers Squibb Company Details
    • 13.6.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
    • 13.6.3 Bristol-Myers Squibb Diabetes Devices and Drugs Introduction
    • 13.6.4 Bristol-Myers Squibb Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 13.6.5 Bristol-Myers Squibb Recent Development and Reaction to COVID-19
  • 13.7 DexCom
    • 13.7.1 DexCom Company Details
    • 13.7.2 DexCom Business Overview and Its Total Revenue
    • 13.7.3 DexCom Diabetes Devices and Drugs Introduction
    • 13.7.4 DexCom Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 13.7.5 DexCom Recent Development and Reaction to COVID-19
  • 13.8 Companion Medical
    • 13.8.1 Companion Medical Company Details
    • 13.8.2 Companion Medical Business Overview and Its Total Revenue
    • 13.8.3 Companion Medical Diabetes Devices and Drugs Introduction
    • 13.8.4 Companion Medical Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 13.8.5 Companion Medical Recent Development and Reaction to COVID-19
  • 13.9 GlaxoSmithKline
    • 13.9.1 GlaxoSmithKline Company Details
    • 13.9.2 GlaxoSmithKline Business Overview and Its Total Revenue
    • 13.9.3 GlaxoSmithKline Diabetes Devices and Drugs Introduction
    • 13.9.4 GlaxoSmithKline Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 13.9.5 GlaxoSmithKline Recent Development and Reaction to COVID-19
  • 13.10 Glenmark Pharmaceuticals
    • 13.10.1 Glenmark Pharmaceuticals Company Details
    • 13.10.2 Glenmark Pharmaceuticals Business Overview and Its Total Revenue
    • 13.10.3 Glenmark Pharmaceuticals Diabetes Devices and Drugs Introduction
    • 13.10.4 Glenmark Pharmaceuticals Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 13.10.5 Glenmark Pharmaceuticals Recent Development and Reaction to COVID-19
  • 13.11 Novartis
    • 10.11.1 Novartis Company Details
    • 10.11.2 Novartis Business Overview and Its Total Revenue
    • 10.11.3 Novartis Diabetes Devices and Drugs Introduction
    • 10.11.4 Novartis Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 10.11.5 Novartis Recent Development and Reaction to COVID-19
  • 13.12 Roche
    • 10.12.1 Roche Company Details
    • 10.12.2 Roche Business Overview and Its Total Revenue
    • 10.12.3 Roche Diabetes Devices and Drugs Introduction
    • 10.12.4 Roche Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 10.12.5 Roche Recent Development and Reaction to COVID-19
  • 13.13 Sanofi
    • 10.13.1 Sanofi Company Details
    • 10.13.2 Sanofi Business Overview and Its Total Revenue
    • 10.13.3 Sanofi Diabetes Devices and Drugs Introduction
    • 10.13.4 Sanofi Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 10.13.5 Sanofi Recent Development and Reaction to COVID-19
  • 13.14 MSD
    • 10.14.1 MSD Company Details
    • 10.14.2 MSD Business Overview and Its Total Revenue
    • 10.14.3 MSD Diabetes Devices and Drugs Introduction
    • 10.14.4 MSD Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 10.14.5 MSD Recent Development and Reaction to COVID-19
  • 13.15 Astrazeneca
    • 10.15.1 Astrazeneca Company Details
    • 10.15.2 Astrazeneca Business Overview and Its Total Revenue
    • 10.15.3 Astrazeneca Diabetes Devices and Drugs Introduction
    • 10.15.4 Astrazeneca Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 10.15.5 Astrazeneca Recent Development and Reaction to COVID-19
  • 13.16 Takeda
    • 10.16.1 Takeda Company Details
    • 10.16.2 Takeda Business Overview and Its Total Revenue
    • 10.16.3 Takeda Diabetes Devices and Drugs Introduction
    • 10.16.4 Takeda Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 10.16.5 Takeda Recent Development and Reaction to COVID-19
  • 13.17 North China Pharmaceutical Group Corporation
    • 10.17.1 North China Pharmaceutical Group Corporation Company Details
    • 10.17.2 North China Pharmaceutical Group Corporation Business Overview and Its Total Revenue
    • 10.17.3 North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Introduction
    • 10.17.4 North China Pharmaceutical Group Corporation Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 10.17.5 North China Pharmaceutical Group Corporation Recent Development and Reaction to COVID-19
  • 13.18 Huadong Medicine
    • 10.18.1 Huadong Medicine Company Details
    • 10.18.2 Huadong Medicine Business Overview and Its Total Revenue
    • 10.18.3 Huadong Medicine Diabetes Devices and Drugs Introduction
    • 10.18.4 Huadong Medicine Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 10.18.5 Huadong Medicine Recent Development and Reaction to COVID-19
  • 13.19 Dongbao Pharmaceutical
    • 10.19.1 Dongbao Pharmaceutical Company Details
    • 10.19.2 Dongbao Pharmaceutical Business Overview and Its Total Revenue
    • 10.19.3 Dongbao Pharmaceutical Diabetes Devices and Drugs Introduction
    • 10.19.4 Dongbao Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 10.19.5 Dongbao Pharmaceutical Recent Development and Reaction to COVID-19
  • 13.20 Hisun Pharmacy
    • 10.20.1 Hisun Pharmacy Company Details
    • 10.20.2 Hisun Pharmacy Business Overview and Its Total Revenue
    • 10.20.3 Hisun Pharmacy Diabetes Devices and Drugs Introduction
    • 10.20.4 Hisun Pharmacy Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 10.20.5 Hisun Pharmacy Recent Development and Reaction to COVID-19
  • 13.21 KELUN
    • 10.21.1 KELUN Company Details
    • 10.21.2 KELUN Business Overview and Its Total Revenue
    • 10.21.3 KELUN Diabetes Devices and Drugs Introduction
    • 10.21.4 KELUN Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 10.21.5 KELUN Recent Development and Reaction to COVID-19
  • 13.22 Ginwa
    • 10.22.1 Ginwa Company Details
    • 10.22.2 Ginwa Business Overview and Its Total Revenue
    • 10.22.3 Ginwa Diabetes Devices and Drugs Introduction
    • 10.22.4 Ginwa Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 10.22.5 Ginwa Recent Development and Reaction to COVID-19
  • 13.23 Tianan Pharmaceutical
    • 10.23.1 Tianan Pharmaceutical Company Details
    • 10.23.2 Tianan Pharmaceutical Business Overview and Its Total Revenue
    • 10.23.3 Tianan Pharmaceutical Diabetes Devices and Drugs Introduction
    • 10.23.4 Tianan Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2015-2020)
    • 10.23.5 Tianan Pharmaceutical Recent Development and Reaction to COVID-19

14Analyst's Viewpoints/Conclusions

    15Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on Covid-19 Impact on Global Diabetes Devices and Drugs. Industry analysis & Market Report on Covid-19 Impact on Global Diabetes Devices and Drugs is a syndicated market report, published as Covid-19 Impact on Global Diabetes Devices and Drugs Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Covid-19 Impact on Global Diabetes Devices and Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,900.00
    		$5,850.00
    		$7,800.00
    		3,108.30
    		4,662.45
    		6,216.60
    		3,623.10
    		5,434.65
    		7,246.20
    		597,597.00
    		896,395.50
    		1,195,194.00
    		325,416.00
    		488,124.00
    		650,832.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo